Tetraphase Pharmaceuticals Now Covered by WBB Securities (TTPH)
WBB Securities began coverage on shares of Tetraphase Pharmaceuticals (NASDAQ:TTPH) in a research note issued on Monday, American Banking and Market News reports. The firm set a “speculative buy” rating on the stock.
In other Tetraphase Pharmaceuticals news, major shareholder Ventures Vi Lp Cmea unloaded 100,000 shares of the company’s stock on the open market in a transaction dated Wednesday, September 18th. The shares were sold at an average price of $10.20, for a total transaction of $1,020,000.00. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Major shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.
Tetraphase Pharmaceuticals (NASDAQ:TTPH) traded down 0.96% during mid-day trading on Monday, hitting $11.38. 60,137 shares of the company’s stock traded hands. Tetraphase Pharmaceuticals has a one year low of $7.00 and a one year high of $11.77. The stock has a 50-day moving average of $9.4 and a 200-day moving average of $8.25. The company’s market cap is $235.2 million.
Separately, analysts at Ladenburg Thalmann initiated coverage on shares of Tetraphase Pharmaceuticals (NASDAQ:TTPH) in a research note to investors on Wednesday, August 21st. They set a “buy” rating and a $13.00 price target on the stock. Seven research analysts have rated the stock with a buy rating, The stock currently has an average rating of “Buy” and an average price target of $13.80.
Tetraphase Pharmaceuticals, Inc, incorporated on July 7, 2006, is a clinical stage biopharmaceutical company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.